Holen Sie sich die Stockscreener-App
51.52
2.59%
1.30
Handel nachbörslich:
52.01
0.49
+0.95%
Finanzdaten der Crispr Therapeutics Ag-Aktie (CRSP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
598.29%
10.18
|
1.458 | 0.864 | 0.889 | 0.892 |
| Operating Expenses |
3.23%
127.45
|
131.71 | 155.63 | 132.95 | 230.22 |
| Operating Income/Loss |
9.96%
-117.27
|
-130.25 | -154.76 | -132.06 | -229.32 |
| Nonoperating Income/Loss |
231.96%
27.07
|
8.156 | 24.77 | 26.24 | 22.07 |
| Income/Loss From Continuing Operations Before Tax |
26.13%
-90.19
|
-122.09 | -130.00 | -105.82 | -207.26 |
| Income Tax Expense/Benefit |
14.42%
0.96
|
0.839 | 0.614 | 0.619 | 1.292 |
| Net Income/Loss |
25.85%
-91.15
|
-122.93 | -130.61 | -106.44 | -208.55 |
| Basic Average Shares |
0.48%
96.51
|
96.05 | 1.8009 | 91.31 | 87.07 |
| Diluted Average Shares |
0.48%
96.51
|
96.05 | 1.8009 | 91.31 | 87.07 |
| Basic Earnings Per Share |
26.56%
-0.94
|
-1.28 | -1.35 | -1.17 | -2.40 |
| Diluted Earnings Per Share |
26.56%
-0.94
|
-1.28 | -1.35 | -1.17 | -2.40 |
0.90%
2.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):